Biosency - About the company
Biosency is a series A company based in Cesson Sevigne (France), founded in 2018 by Gilles Giannoli and Marie Pirotais. It operates as a Provider of smart band and platform for remote patient monitoring. Biosency has raised $8.42M in funding from GO CAPITAL. The company has 349 active competitors, including 79 funded and 18 that have exited. Its top competitors include companies like Vivalink, Aevice Health and Strados Labs.
Company Details
Provider of smart band and platform for remote patient monitoring. The company offers a smart band to remotely monitor the outpatient's health and predict the insights on system failure prior to better treatment planning and engagement.
- Website
- biosency.com
- Social
- Email ID
- *****@biosency.com
- Phone Number
- +33 **********
Key Metrics
Founded Year
2018
Location
Cesson Sevigne, France
Stage
Series A
Total Funding
$8.42M in 2 rounds
Latest Funding Round
Investors
Ranked
21st among 349 active competitors
Employee Count
23 as on Aug 31, 2026
Similar Companies
Sign up to download Biosency's company profile
Biosency's funding and investors
Biosency has raised a total funding of $8.42M over 2 rounds. Its first funding round was on 2018. Its latest funding round was a Series A round on Nov 10, 2023 for $*****. 1 investor participated in its latest round. Biosency has 1 institutional investor.
Here is the list of recent funding rounds of Biosency:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 10, 2023 | 5044412 | Series A | 4506640 | 9551681 | 9834739 | 3308383 |
2018 | 8134 | Seed | 1695 | 7203 | 6018 |
Access funding benchmarks and valuations. Sign up today!View details of Biosency's funding rounds and investors
Biosency's founders and board of directors
Founder? Claim ProfileThe founders of Biosency are Gilles Giannoli and Marie Pirotais.
Here are the details of Biosency's key team members:
- Gilles Giannoli: Co-Founder & CMO of Biosency.
- Marie Pirotais: Co-Founder & CEO of Biosency.
View details of Biosency's Founder profiles and Board Members
Biosency's employee count trend
Biosency has 23 employees as of Aug 26. Here is Biosency's employee count trend over the years:
Uncover Biosency's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biosency's Competitors and alternates
Top competitors of Biosency include Vivalink, Aevice Health and Strados Labs. Here is the list of Top 10 competitors of Biosency, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Vivalink 2014, Campbell (United States), Seed | Provider of wearable sensors and digital health solutions for monitoring | $1.54M | 59/100 | |
2nd | Aevice Health 2016, Singapore (Singapore), Seed | Provider of wearable devices to track respiratory conditions | $9.11M | 58/100 | |
3rd | Strados Labs 2016, Philadelphia (United States), Series A | Provider of a wearable device for breathing monitoring | $6.36M | 56/100 | |
4th | Developer of a patch to monitor and provide insights about patients health | $39.6M | 56/100 | ||
5th | Healbe 2012, Redwood City (United States), Series A | Smart bands for comprehensive health tracking and lifestyle improvement | $2.8M | 55/100 | |
6th | Propeller Health 2010, Madison (United States), Acquired | Mobile platform and a sensor for respiratory health management | $64M | 55/100 | |
7th | Liberate Medical 2013, Louisville (United States), Series B | Developing respiratory muscle stimulator technology to liberate patients from mechanical ventilation | $11.3M | 54/100 | |
8th |  Samay 2018, Mountain View (United States), Seed | Provider of a device for continuous monitoring of lung health | - | 53/100 | |
9th | Provider of clinical decision support tools for respiratory diseases | $28.1M | 52/100 | ||
10th | TidalSense 2013, Cambridge (United Kingdom), Series A | AI-based device to detect respiratory conditions | $40M | 52/100 | |
21st | Provider of smart band and platform for remote patient monitoring | $8.42M | 45/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Biosency's competitors? Click here to see the top ones
Biosency's Investments and acquisitions
Biosency has made no investments or acquisitions yet.
Reports related to Biosency
Here is the latest report on Biosency's sector:
News related to Biosency
Media has covered Biosency for 1 event in last 1 year.
•
Withings acquires Biosency to expand respiratory offeringsMobiHealthNews•Jun 24, 2026•Withings, Biosency
•
Biosency raises 7 million euros to support patients with respiratory failureusine-digitale.fr•Nov 10, 2023•Biosency, GO CAPITAL
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Biosency
Explore our recently published companies
- Alfresco - London based, 1996 founded, Unfunded company
- Katana Sports - 2022 founded, Unfunded company
- Anand Rathi - Mumbai based, 1994 founded, Public company
- Providence Health & Services - United States based, 1859 founded, Funding Raised company
- Entekhaabco - Kuwait City based, 2019 founded, Unfunded company
- Glovnetics - Gurugram based, 2022 founded, Unfunded company
